Masaoki Ito

8PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C.

Masaoki Ito, Yoshihiro Miyata, Shoko Hirano

|Apr 17, 2023
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.

Koichi Tomoshige, William D Stuart, Iris M Fink-Baldauf

|Jul 04, 2021
Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma.

Masaoki Ito, Yoshihiro Miyata, Shoko Hirano

|Apr 02, 2021
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.

Daisuke Ueda, Masaoki Ito, Yasuhiro Tsutani

Pageof 2